Inactivation of Zika Virus with Hydroxypropyl-Beta-Cyclodextrin
<b>Background/Objectives</b>: Zika virus (ZIKV) infection is associated with life-threatening diseases in humans. To date, there are no available FDA-approved therapies or vaccines for the specific treatment or prevention of ZIKV infection. Variation in the ZIKV envelope protein (Env), a...
Saved in:
Main Authors: | Cory R. Hewitt, Nicholas J. Wixon, Arthur Gallegos, You Zhou, Victor C. Huber, M. Scott Killian |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2025-01-01
|
Series: | Vaccines |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-393X/13/1/79 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Complexation of Z-ligustilide with hydroxypropyl-β-cyclodextrin to improve stability and oral bioavailability
by: Lu Yapeng, et al.
Published: (2014-06-01) -
Assessing the effect of beta-propiolactone inactivation on the antigenicity and immunogenicity of cluster 2.1 duck Tembusu virus
by: Kanana Rungprasert, et al.
Published: (2025-03-01) -
A superior preparation method for daidzein-hydroxypropyl-β-cyclodextrin complexes with improved solubility and dissolution: Supercritical fluid process
by: Pan Hao, et al.
Published: (2017-03-01) -
Zika, a Mosquito-Transmitted Virus
by: L. Phil Lounibos, et al.
Published: (2016-02-01) -
Zika, a Mosquito-Transmitted Virus
by: L. Phil Lounibos, et al.
Published: (2016-02-01)